AbbVie (ABBV) Earnings: 4Q20 Key Numbers
AbbVie Inc. (NYSE: ABBV) reported fourth quarter 2020 earnings results today. Worldwide net revenues rose 59.2% year-over-year to $13.8 billion on a reported basis. On…
Analysis
AbbVie (ABBV) to focus more on pipeline as recovery gathers pace
AbbVie, Inc. (NYSE: ABBV) has been recovering steadily from the virus-related slowdown and latest statistics show that the company’s performance has improved to pre-crisis levels…
AbbVie Inc. (ABBV) Q3 2020 Earnings Call Transcript
AbbVie Inc. (NYSE: ABBV) Q3 2020 earnings call dated Oct. 30, 2020 Corporate Participants: Liz Shea — Investor Relations Richard A. Gonzalez — Chairman of the Board and Chief…
Analysis
Strong performance of oncology products bode well for AbbVie (ABBV) going forward
AbbVie Inc. (NYSE: ABBV) reported better-than-expected results for the second quarter of 2020 on Friday. The company reported a 26% increase in total revenue to…
ADVERTISEMENT
AlphaGraphs
AbbVie (ABBV) Q2 2020 results beat estimates; updates FY20 outlook
AbbVie (NYSE: ABBV), which completed the acquisition of Allergan on May 8, 2020, reported second quarter 2020 earnings results today. The company’s adjusted earnings and…
Market News
COVID-19 favors AbbVie (ABBV) in reporting upbeat Q1 results
AbbVie (NYSE: ABBV), which is expecting to close the acquisition of Allergan in this month, reported its first quarter 2020 earnings results last Friday. The…
AbbVie Inc (NYSE: ABBV) Q1 2020 Earnings Call Transcript
AbbVie Inc (ABBV) Q1 2020 earnings call dated May. 01, 2020 Corporate Participants: Liz Shea — Vice President, Investor Relations Richard A. Gonzalez — Chairman of the Board and…
AbbVie Inc (NYSE: ABBV) Q4 2019 Earnings Call Transcript
AbbVie Inc (NYSE: ABBV) Q4 2019 Earnings Conference Call February 07, 2020 Corporate Participants: Liz Shea — Vice President of Investor Relations Richard A. Gonzalez — Chairman of the Board…
ADVERTISEMENT
AlphaGraphs
Fresh hope for Covid-19 patients as AbbVie (ABBV) leads studies on HIV drug
For some of the leading drugmakers, currently, the first priority is to find an effective treatment for Covid-19, which was declared a pandemic by the…
Market News
AbbVie (ABBV) Q4 earnings preview: Generic competition might weigh on results
With only a few weeks left for closing the high-value acquisition of Allergan, AbbVie (NYSE: ABBV) is busy doing the groundwork for the integration. The…